To include your compound in the COVID-19 Resource Center, submit it here.

FDA grants Priority Review to Siga's smallpox candidate

Siga Technologies Inc. (Pink:SIGA) said FDA accepted

Read the full 72 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE